课题基金 / 基金详情

项目摘要

项目成果

ROBERT Louis VESSELLA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In this renewal resubmission, we. propose to continue studies on prostate cancer (CaP) metastasis, especially focusing on the dissemination and growth of CaP in bone. This effort has coordinated much previous work from a variety of sources within the University of Washington (UW) milieu and is multidisciplinary, incorporating cancer and bone biology, cancer endocrinology, pathology and genomics. Institutional partners include the Fred Hutchinson Cancer Research Center and the UW Institute of Stem Cell Sciences. Inquiries into the mechanisms of CaP bone metastasis, are poorly studied, in part because of a lack of appropriate animal models and specimens. As the Progress Reports will demonstrate, these limitations have been largely overcome by our investigators, and the derived resources will enable the pursuit of the scientific objectives proposed. This P01 consists of 3 projects and 2 cores. Project 1 is entitled "The Detection, Isolation and Characterization of Disseminated Tumor Cells". This project will genomically characterize the DTC, looking at correlates to progression and biological function. It incorporates multiple studies exploring the stem cell aspects of DTC and the role of DTC in tumor dormancy. This is a new project, led by Dr. Robert Vessella that replaces the previous Project 1. Project 2 is entitled "Transmembrane Proteases and Prostate Carcinogenesis". This project, led by Dr. Pete Nelson, will focus heavily on the serine protease TMPRSS2 and the gene fusion TMPRSS2-ERG. Project 3 is entitled: "Determinants of Response to Type 1 Insulin-like Growth Factor Inhibition in Prostate Cancer". This project is led by Dr. Steve Plymate and is highly translational as it is focused on better understanding the role of IGF-1R as clinical trials at UW and elsewhere are being conducted to target this receptor. Projects 2 and 3 are continuations of very successful studies during the current funding period. Core A is the Biospecimen Core which acquires processes and distributes biospecimens. It also conducts pre-clinical xenograft studies and provides statistical support to the overall P01 program. Core B is the Administrative Core which provides overall administrative support to the investigators.
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1078-0432.ccr-09-0264
发表时间: 2009-12-15
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者: [Sprenger CC, Haugk K, Sun S, Coleman I, Nelson PS, Vessella RL, Ludwig DL, Wu JD, Plymate SR]
通讯作者: Plymate SR
DOI: 10.1371/journal.pone.0035876
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pöhlmann S, Soilleux EJ]
通讯作者: Soilleux EJ
DOI: 10.1186/1471-2407-9-452
发表时间: 2009-12-18
期刊: BMC cancer
影响因子: 3.8
作者: [Pascal LE, Vêncio RZ, Page LS, Liebeskind ES, Shadle CP, Troisch P, Marzolf B, True LD, Hood LE, Liu AY]
通讯作者: Liu AY
DOI: 10.1186/1471-2490-7-3
发表时间: 2007-03-02
期刊: BMC urology
影响因子: 2
作者: [Dall'Era MA, True LD, Siegel AF, Porter MP, Sherertz TM, Liu AY]
通讯作者: Liu AY
17
    Facility Biospecimen and Xenograft Core
    Profiling and Characterizing Prostate Cancer Tumor Dormancy in the Bone Marrow
    • 批准号:
      7943979
    • 项目类别:
    • 资助金额:
      $49.96万
    • 财政年份:
      2009
    • 负责人:
      ROBERT Louis VESSELLA
    • 依托单位:
    Profiling and Characterizing Prostate Cancer Tumor Dormancy in the Bone Marrow
    • 批准号:
      7809196
    • 项目类别:
    • 资助金额:
      $49.92万
    • 财政年份:
      2009
    • 负责人:
      ROBERT Louis VESSELLA
    • 依托单位:
    Tissue and Specimen Core
    海外基金